[vic-]trastuzumab duocarmazine shows improved pfs in pre-treated her2 locally advanced or metas...
Published 2 years ago • 23 plays • Length 4:15Download video MP4
Download video MP3
Similar videos
-
2:00
tulip: trastuzumab duocarmazine improved pfs in pre-treated her2 breast cancer
-
2:49
trastuzumab duocarmazine for her2 locally advanced or metastatic cancer
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
5:46
adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for her2-positive breast cancer
-
5:29
adding lapatinib to adjuvant trastuzumab doesn't improve outcomes in her2-positive breast cancer
-
1:01:35
her2 treatment
-
9:13
substituting trastuzumab emtansine for adjuvant trastuzumab improved idfs for breast cancer pati...
-
4:34
the best sequence of anti-her2 therapy in metastatic breast cancer
-
4:44
an overview of recent metastatic her2 breast cancer trials
-
3:51
study comparing margetuximab combinations to trastuzumab combinations in her2-positive breast cancer
-
1:47
her2climb-05: tucatinib trastuzumab and pertuzumab as maintenance therapy for her2 metastatic bc
-
10:05
piii trial supports current standard 12-month adjuvant trastuzumab for her2-positive breast cancer
-
1:12
her2climb-04: tucatinib trastuzumab deruxtecan in her2 breast cancer
-
2:09
the evolution of her2 targeting in metastatic breast breast cancer
-
5:11
antibody drug conjugates for gastric cancer
-
2:31
dr. peter beitsch on pertuzumab in luminal subtype breast cancer
-
7:42
results from the aphinity trial of two her2 targeted agents with chemo
-
1:47
results of a phase iii trial on ct-p6, a trastuzumab biosimilar candidate, in early breast cancer
-
5:30
antibody drug conjugates of trastuzumab for her2 mbc